[go: up one dir, main page]

PL3661491T3 - 3-metylometkatynon do zastosowania w leczeniu pacjenta poddawanego interwencji psychoterapeutycznej - Google Patents

3-metylometkatynon do zastosowania w leczeniu pacjenta poddawanego interwencji psychoterapeutycznej

Info

Publication number
PL3661491T3
PL3661491T3 PL18765723.4T PL18765723T PL3661491T3 PL 3661491 T3 PL3661491 T3 PL 3661491T3 PL 18765723 T PL18765723 T PL 18765723T PL 3661491 T3 PL3661491 T3 PL 3661491T3
Authority
PL
Poland
Prior art keywords
methylmethcathinone
treating
subject undergoing
psychotherapeutic intervention
psychotherapeutic
Prior art date
Application number
PL18765723.4T
Other languages
English (en)
Inventor
Ezekiel Golan
Mark HADEN
Rene VAN WETTUM
Original Assignee
Ezekiel Golan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ezekiel Golan filed Critical Ezekiel Golan
Publication of PL3661491T3 publication Critical patent/PL3661491T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18765723.4T 2017-08-03 2018-08-02 3-metylometkatynon do zastosowania w leczeniu pacjenta poddawanego interwencji psychoterapeutycznej PL3661491T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762540617P 2017-08-03 2017-08-03
PCT/IB2018/055812 WO2019026019A1 (en) 2017-08-03 2018-08-02 USE OF 3-METHYLMETHCATHINONE

Publications (1)

Publication Number Publication Date
PL3661491T3 true PL3661491T3 (pl) 2025-08-11

Family

ID=63517938

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18765723.4T PL3661491T3 (pl) 2017-08-03 2018-08-02 3-metylometkatynon do zastosowania w leczeniu pacjenta poddawanego interwencji psychoterapeutycznej

Country Status (12)

Country Link
US (1) US20200360311A1 (pl)
EP (1) EP3661491B1 (pl)
JP (1) JP7273037B2 (pl)
AU (1) AU2018309420B2 (pl)
CA (1) CA3072780C (pl)
ES (1) ES3034024T3 (pl)
FI (1) FI3661491T3 (pl)
HU (1) HUE072199T2 (pl)
PL (1) PL3661491T3 (pl)
PT (1) PT3661491T (pl)
SI (1) SI3661491T1 (pl)
WO (1) WO2019026019A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7638967B2 (ja) * 2019-08-26 2025-03-04 ピリオド ピル ベーフェー 月経周期性症状の治療
AU2021267101B2 (en) * 2020-05-05 2024-03-28 Universitätsspital Basel MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin or other psychedelics
WO2022150525A1 (en) 2021-01-06 2022-07-14 Awakn Life Sciences Mdma in the treatment of alcohol use disorder
US20220358130A1 (en) * 2021-05-10 2022-11-10 International Business Machines Corporation Identify and explain life events that may impact outcome plans
CA3249142A1 (en) 2022-01-19 2023-07-27 Awakn Ls Europe Holdings Ltd 1,3-BENZODIOXOLE ESTERS AND THEIR THERAPEUTIC USE
US20250179089A1 (en) 2022-02-16 2025-06-05 Awakn Ls Europe Holdings Limited Bridged ring compounds and their therapeutic use as cns agents
WO2025196662A1 (en) * 2024-03-20 2025-09-25 Clearmind Labs Corp. Compositions and methods for treating eating disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011001384A (es) 2008-08-06 2011-09-27 Gosforth Ct Holdings Pty Ltd Composiciones y metodos para tratar trastornos psiquiatricos.
WO2010054286A2 (en) 2008-11-10 2010-05-14 Auspex Pharmaceuticals, Inc. Substituted hydroxyphenylamine compounds

Also Published As

Publication number Publication date
JP2020530032A (ja) 2020-10-15
FI3661491T3 (fi) 2025-06-26
EP3661491B1 (en) 2025-03-26
US20200360311A1 (en) 2020-11-19
AU2018309420A1 (en) 2020-03-12
AU2018309420B2 (en) 2023-02-16
EP3661491A1 (en) 2020-06-10
SI3661491T1 (sl) 2025-08-29
HUE072199T2 (hu) 2025-10-28
JP7273037B2 (ja) 2023-05-12
PT3661491T (pt) 2025-07-24
CA3072780A1 (en) 2019-02-07
WO2019026019A1 (en) 2019-02-07
NZ762060A (en) 2024-07-26
CA3072780C (en) 2023-10-24
ES3034024T3 (en) 2025-08-12

Similar Documents

Publication Publication Date Title
IL272596A (en) Pridopidine for use in the treatment of ALS
SI3661491T1 (sl) 3-metilmetkatinon za uporabo pri zdravljenju posameznika, ki je izpostavljen psihoterapevtski intervenciji
IL278124B (en) Axl depressant pyridone derivative for use in the treatment of the disease
ZA201705673B (en) Methods for treating skin
EP3277378C0 (en) DEVICE FOR THE TREATMENT OF VASCULAR DISEASES
PL3173957T3 (pl) Dystrybucja zestawu danych podczas działania urządzenia medycznego
PL3683351T3 (pl) Urządzenie do obróbki prania
IL278247B (en) mct4 inhibitors to treat the disease
HUE058323T2 (hu) Egy BTK-inhibitor rák kezelésében történõ alkalmazásra
IL254393A0 (en) Methods for treating diseases associated with pathological changes in protein
SI3710000T1 (sl) Tradipitant za uporabo pri zdravljenju gastropareze
PT3164394T (pt) Inibidores gls1 para o tratamento de doenças
IL250980A0 (en) Mucolytic agents for use in the treatment of pulmonary sarcoidosis
PL4008329T3 (pl) Związki izoksazoliny do zastosowania w leczeniu demodekozy
PL2913284T3 (pl) Sposób oraz urządzenie do obróbki części
ZA201701426B (en) Compounds for use in anthelminthic treatment
PL2949399T3 (pl) Urządzenie do obróbki artykułów drewnianych
IL252904A0 (en) Methods and factors for treating diseases
ZA201800632B (en) Method for treating diseases in plants
SI3406258T1 (sl) Zdravilo za zdravljenje putike
PL3207892T3 (pl) Aparat do zabiegów częstotliwościami radiowymi
PT3250218T (pt) Péptido natkide para o tratamento da obesidade
EP3148525C0 (en) CAFESTOL FOR TREATING DIABETES
GB201522578D0 (en) Bed warming apparatus and a method for bed warming
GB201512343D0 (en) A heater for use in curing tobacco or for other similar processes